Neurol. praxi. 2013;14(2):84-88

Epilepsy in patients with multiple sclerosis

MUDr.Zuzana Čarnická, MUDr.Katarína Klobučníková, PhD., MUDr.Pavel Šiarnik, MUDr.Lucia Krížová, doc.MUDr.Branislav Kollár, PhD., prof.MUDr.Peter Turčáni, PhD.
I. neurologická klinika LF UK a UN, Bratislava

Epilepsy and multiple sclerosis (MS) are disorders often seen in daily clinical praxis by neurologists. Rarely they occur together. Then

question about their pathophysiological relation logically arises. New knowledge about the pathophysiology of these two disorders and

progress of neuroimaging methods should be helpful in clarifying the relationship between these two disorders. According to several

epidemiological studies, which analyzed the incidence and risk of epilepsy in patients with MS, the incidence of seizures is higher in

patients with MS and seizures are caused by cortical and subcortical lesions and by their accompanying oedema. In this article authors

conclude current knowledge of coincidence of both diseases.

Keywords: epilepsy, multiple sclerosis, cortical lesions, antiepileptic therapy

Published: April 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čarnická Z, Klobučníková K, Šiarnik P, Krížová L, Kollár B, Turčáni P. Epilepsy in patients with multiple sclerosis. Neurol. praxi. 2013;14(2):84-88.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Albert M, Antel J, Bruck W, Stadelmann C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 2007; 2:129-138. Go to original source... Go to PubMed...
    2. Avonex SPC 2013. Dostupné na: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm085930.pdf.
    3. Betaseron SPC. 2013. Dostupné na: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088565.pdf.
    4. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25: 315-320. Go to original source... Go to PubMed...
    5. B? L, Vedeler CA, Nyland HI, Trapp BD, M?rk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003; 7: 723-732. Go to original source...
    6. Calabrese M, Grossi P, Favaretto A, Romualdi C, Atzori M, Rinaldi F, Perini P, Saladini M, Gallo P. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry 2012; 83: 49-54. Go to original source... Go to PubMed...
    7. Copaxone SPC. 2009. Dostupné na: http://www.fda.gov/cder/foi/label/2001/20622s15lbl.pdf.
    8. Chabolla DR, Moore JL, Westmoreland BF. Periodic lateralized epileptiform discharges in multiple sclerosis. Electroencephalography Clin Neurophys 1996; 1: 5-8. Go to original source... Go to PubMed...
    9. Dolezal O, Dwyer MG, Horakova D, Havrdova E, Minagar A, Balachandran S, Bergsland N, Seidl Z, Vaneckova M, Fritz D. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis. International review of neurobiology 2007; 79: 475-489. Go to original source... Go to PubMed...
    10. Engelsen BA, Gronning M. Epileptic seizures in patient with multiple sclerosis. Is the prognosis of epilepsy underestimated? Seizure 1997; 3: 377-82. Go to original source... Go to PubMed...
    11. Grabow JD. Optimal recordings techniques and activation procedures: childrens and adults In: JA Wada, RJ Ellingson. Clinical neurophysiology of epilepsy. Elsevier Science, Amsterdam 1990; 39-77 (EEG handbook, revised series, vol. 4).
    12. Horakova D, Kalincik T, Blahova Dusankova J, Dolezal O. Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurology 2012; 12: 10. Go to original source... Go to PubMed...
    13. Kermode AG, Tofts PS, Thompson AJ. Heterogenity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40: 229-235. Go to original source... Go to PubMed...
    14. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain.1999; 122:17-26. Go to original source... Go to PubMed...
    15. Klobučníková, K. Výskyt epilepsie u pacientov so sklerózou multiplex - literárny prehľad a kazuistika. Čes Slov Neurol Neurochir 2001; 3: 212-216.
    16. Koch M, Uyttenboogaart M, Polman S, De Keyser J. Seizures in multiple sclerosis. Epilepsia 2008; 49: 948-953. Go to original source... Go to PubMed...
    17. Leube W. Ueber multiple inselförmige Sklerose des Gehirns und Rückenmarks. Nach Beobachtungen aus der Erlanger medicinischen Klinik. Dtsch Arch Klin Med 1871; 8: 1-29.
    18. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634-642. Go to original source... Go to PubMed...
    19. Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah Ch, Rammohan K, Knopp M, Schmalbrock P. Imaging Cortical Lesions in Multiple Sclerosis With Ultra-High-Field Magnetic Resonance Imaging. Arch Neurol. 2010; 7: 812-818. Go to original source... Go to PubMed...
    20. Poser CM, Brinar VV. Epilepsy and multiple sclerosis. Epil Behav 2003; 4: 6-12. Go to original source... Go to PubMed...
    21. Rebif SPC. 2013. Dostupné na: http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089019.pdf.
    22. Sander JW, Hart YM, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990; 336: 1267-1271.
    23. Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003; 16: 165-170. Go to original source... Go to PubMed...
    24. Sokić DV, Stojsavljević N, Drulović J, Dujmović, I, Mesaroš Š, Ercegovac M, Perić V, Dragutinović G, Lević Z. Seizures in Multiple Sclerosis. Epilepsia 2001; 42: 72-79. Go to original source... Go to PubMed...
    25. Sotgiu S, Murrighile MR, Constantin G. Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC Neurol. 2010; 10: 84. Go to original source... Go to PubMed...
    26. Spatt J, Goldenberg G, Mamoli B. Simple Dysphasic Seizures as the Sole Manifestation of Relapse in Multiple Sclerosis. Epilepsia 1994; 35: 1342-1345. Go to original source... Go to PubMed...
    27. Spatt J, Chaix R, Mamoli B. Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol 2001; 248: 2-9. Go to original source... Go to PubMed...
    28. Striano P, Orefice G, Brescia Morra V, Boccella P, Sarappa C, Lanzillo R, Vacca G, Striano S. Epileptic seizures in multiple sclerosis: clinical and EEG correlations. Neurol Sci 2003; 5: 322-328. Go to original source... Go to PubMed...
    29. Thompson AJ, Kermode AG, Moseley IF, MacManus DG, McDonald WI. Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol Neurosurg Psychiatry 1993; 56: 1317-1320. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.